[ad_1] Dr. Ciulla recently presented and served as a panel member at the American Society of Retina Specialists annual meeting in Vienna, Austria. [ad_2] Return to main website.
[ad_1] Recent publication by Dr. Ciulla describing the relationship between the vitreous and treatment outcomes in age-related macular degeneration…. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related… Bar graph showing the mean (standard error) number of treatments by total number …
[ad_1]
Good explanation of pupil dilation for retinal examination…
Dilating eye drops are a critical tool that allows your ophthalmologist to look at the inside of your eye. Learn what to expect when your eyes are dilated: http://buzz.mw/b6rln_n
[ad_2]
Return to main website.
[ad_1] Recent update with Dr. Ciulla on the Phase 2B trial of Squalamine for wet AMD… Impact of the OHR-102 IMPACT Data A closer look at combination therapy and CNV. [ad_2] Return to main website.
[ad_1] Dr. Ciulla’s surgical technique featured on RetinaLink… Dr. Thomas Ciulla: Gaining an Edge with the FINESSE™Flex Loop – Welcome to RetinaLink There are varying opinions in the Retina world on the optimal way to peel the ILM, Internal Limiting Membrane. Dr. Thomas A. Ciulla, …
[ad_1]
Dr. Ciulla recently authored a review on a new indication for Lucentis and Eylea, which have been shown to slow the progression of diabetic retinopathy…
Anti-VEGF Therapy to Limit DR Progression
Although many questions remain, anti-VEGF therapies for diabetic retinopathy treatment will dramatically alter the delivery of care.
[ad_2]
Return to main website.
[ad_1] Many of us take sight for granted….[fb_vid id=”10153009561916130″]Watch someone’s reaction when they see for the first time via Pixable. [ad_2] Return to main website.
[ad_1] A recent article authored by Dr. Ciulla regarding new treatments for diabetic macular edema… Corticosteroids for Diabetic Macular Edema As diabetes becomes more common, a large unmet need has arisen for long-acting corticsteroid implants to treat the disorder. [ad_2] Return to main website.
[ad_1]
A recent article authored by Dr. Ciulla regarding a macular degeneration treatment currently in phase 2 clinical trial…
http://www.visioncareprofessional.com/emails/amdupdate/index.asp?issue=78
Squalamine is a small molecule drug, which has been shown to inhibit multiple angiogenic growth factors including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and basic fibroblast growth factor (bFGF). It does so through a novel intracellular mechanism, which inv…
[ad_2]
Return to main website.
[ad_1] This is a good summary of a common problem… What Are Floaters and Flashes? – Eye M.D.-approved information from EyeSmart Floaters are specks, strings or webs of material that can be seen floating in your vision. They are caused by cells or strands in …